DE3540632C2 - - Google Patents

Info

Publication number
DE3540632C2
DE3540632C2 DE3540632A DE3540632A DE3540632C2 DE 3540632 C2 DE3540632 C2 DE 3540632C2 DE 3540632 A DE3540632 A DE 3540632A DE 3540632 A DE3540632 A DE 3540632A DE 3540632 C2 DE3540632 C2 DE 3540632C2
Authority
DE
Germany
Prior art keywords
carnosine
immune
reaction
mouse
pfc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3540632A
Other languages
German (de)
English (en)
Other versions
DE3540632A1 (de
Inventor
Kineshiro Tokio/Tokyo Jp Nagai
Taiko Kashiwa Chiba Jp Suda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon University
Original Assignee
Nihon University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon University filed Critical Nihon University
Publication of DE3540632A1 publication Critical patent/DE3540632A1/de
Application granted granted Critical
Publication of DE3540632C2 publication Critical patent/DE3540632C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE19853540632 1985-02-13 1985-11-15 Immun-regulator Granted DE3540632A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60025494A JPS61186322A (ja) 1985-02-13 1985-02-13 免疾調節剤

Publications (2)

Publication Number Publication Date
DE3540632A1 DE3540632A1 (de) 1986-08-21
DE3540632C2 true DE3540632C2 (en, 2012) 1992-09-17

Family

ID=12167607

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19853540632 Granted DE3540632A1 (de) 1985-02-13 1985-11-15 Immun-regulator

Country Status (9)

Country Link
US (1) US4717716A (en, 2012)
JP (1) JPS61186322A (en, 2012)
CH (1) CH666188A5 (en, 2012)
DE (1) DE3540632A1 (en, 2012)
DK (1) DK171288B1 (en, 2012)
FR (1) FR2577138B1 (en, 2012)
GB (1) GB2170707B (en, 2012)
NL (1) NL8600112A (en, 2012)
SE (1) SE466787B (en, 2012)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6314728A (ja) * 1986-07-03 1988-01-21 Zeria Shinyaku Kogyo Kk 肝障害の予防、治療剤
US4942530A (en) * 1987-03-02 1990-07-17 Mazda Motor Corporation Control of vehicle automatic transmission
US5110600A (en) * 1988-01-25 1992-05-05 The Regents Of The University Of California Method of treating viral infections with amino acid analogs
JPH0235057A (ja) * 1988-04-26 1990-02-05 Kinuko Nagai 機能性食品
JPH0717505B2 (ja) * 1989-02-23 1995-03-01 絹子 永井 骨粗鬆症予防剤
DK0593585T3 (da) * 1991-07-05 2002-08-19 Peptech Ltd Peptid, som modvirker TNF- og LPS-toksicitet
ATE191147T1 (de) * 1991-07-26 2000-04-15 Commw Scient Ind Res Org System der bereitstellung eines impfstoffes auf peptidbasis, das sein eigenes adjuvans bildet, und seine herstellung
DE69231576T2 (de) * 1991-09-09 2001-06-13 Kings College London, London Verwendung von Peptiden ZUR BEHANDLUNG VON KOMPLIKATIONEN UND PATHOLOGY BEI DIABETES
AU660047B2 (en) * 1991-09-09 1995-06-08 King's College London Method for the treatment of the complications and pathology of diabetes
RU2058553C1 (ru) * 1994-03-18 1996-04-20 Иван Николаевич Головистиков Способ определения супрессорного звена иммунного статуса человека
RU2056852C1 (ru) * 1994-03-18 1996-03-27 Иван Николаевич Головистиков Средство для лечения аутоиммунных заболеваний с иммунодефицитом супрессоров и способ лечения аутоиммунных заболеваний
US5576287A (en) * 1994-04-29 1996-11-19 Wake Forest University Method for treating acute renal disease and failure
KR960010020A (ko) 1994-09-09 1996-04-20 도리이 신이치로 조혈 기능 항진제
JPH0881371A (ja) * 1994-09-09 1996-03-26 Suntory Ltd 造血機能亢進剤
JP3877807B2 (ja) * 1996-07-03 2007-02-07 ゼリア新薬工業株式会社 口内炎治療・予防剤
JPH1029939A (ja) * 1996-07-17 1998-02-03 Zeria Pharmaceut Co Ltd 創傷治癒促進剤
RU2010113994A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение панкреатического полипептида человека в качестве терапевтического средства
IT1391251B1 (it) * 2008-10-15 2011-12-01 Innovative Nutrition & Pharma Srl Composizione per il trattamento delle patologie articolari
JP2012219080A (ja) * 2011-04-12 2012-11-12 Anbas:Kk 経口投与により腫瘍の発生又は増殖を抑止する組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446149A (en) * 1981-12-14 1984-05-01 Kineshiro Nagai Medicine for treatment of cervical erosion
JPS6016934A (ja) * 1983-07-06 1985-01-28 Kaneshiro Nagai 抗腫瘍剤

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen

Also Published As

Publication number Publication date
JPS61186322A (ja) 1986-08-20
FR2577138B1 (fr) 1990-06-22
JPH0481966B2 (en, 2012) 1992-12-25
DK500585D0 (da) 1985-10-31
DK500585A (da) 1986-08-14
DK171288B1 (da) 1996-08-26
DE3540632A1 (de) 1986-08-21
FR2577138A1 (fr) 1986-08-14
US4717716A (en) 1988-01-05
SE8505121L (sv) 1986-08-14
SE8505121D0 (sv) 1985-10-30
NL8600112A (nl) 1986-09-01
GB2170707B (en) 1989-02-15
CH666188A5 (de) 1988-07-15
GB2170707A (en) 1986-08-13
GB8527243D0 (en) 1985-12-11
SE466787B (sv) 1992-04-06

Similar Documents

Publication Publication Date Title
DE3540632C2 (en, 2012)
DE69901396T2 (de) Zusammensetzung enthaltend beta-hydroxy-beta-methylbutyratsäuere und mindestens ein aminosäure
DE2147111C3 (de) Verwendung von 3-<4-Biphenylcarbonyl)propionsäure
DE2709820C2 (de) N-(Mercaptoacyl)-L oder DL-cysteine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende mucolytische Mittel
DE69030616T2 (de) Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion
EP0607775B1 (de) Verwendung von Leflunomid zur Hemmung von Interleukin 1 beta
DE3891468C2 (de) Äthylester der 6-Brom-5-hydroxy-4-dimethylaminomethyl-1-methyl-2-phenylthiomethylindol-3-karbonsäure des monohydrat-hydrogenchlorids, Verfahren zu seiner Herstellung und Arzneipräparat mit antiviraler, interferoninduzierender und immunomodulierender Wirkung auf seiner Grundlage
DE69424777T2 (de) 3,4-diarylchromane zur behandlung von dermatitis
DE3137125C2 (en, 2012)
DE69227696T2 (de) Zusammensetzungen zur behandlung von hiv-infektionen
DE68915269T2 (de) Polyvalentes entzündungshemmendes mittel.
DE2947624A1 (de) Beta, gamma -dihydropolyprenylalkohol und diesen enthaltendes blutdrucksenkendes arzneimittel
DD238920A5 (de) Verfahren zur herstellung einer verbesserten entzuendungshemmend wirkenden zusammensetzung
CH615410A5 (en) Process for the preparation of novel alpha-ethylbenzhydrol derivatives
DE69024060T2 (de) Osteogenesis-stimulierende mittel.
DE68907268T2 (de) Verwendung von Phytinsäure als Antidot gegen Alkoholvergiftung.
DD201797A5 (de) Verfahren zur herstellung von dihydro-1h-pyrrolizin-3,5(2h,6h)-dion
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
DE2623486C2 (de) 3.5.5-Trimethylhexanoyl-ferrocen, Verfahren zu seiner Herstellung und pharmazeutische Präparate
DE2351345A1 (de) Therapeutische zubereitung
DE68903448T2 (de) Pharmazeutische und/oder diaetetische zusammensetzungen mit gehalt an l-carnitin und l-lysin.
DE3141970C2 (en, 2012)
DE2364704C2 (de) Ca-Doppelsalz des Lysins und der Chlorwasserstoffsäure und dessen pharmakologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und diese Säureadditionssalze enthaltende Arzneimittel
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE3419425C2 (en, 2012)

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee